| Name | Title | Contact Details |
|---|
Pyxis is a El Dorado, KS-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Sophono is a Boulder, CO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
We specialize in full-service senior living communities that offer an enriched lifestyle drawn from thoughtful details. When Andrew Kohlberg, our founder and president, purchased Kisco`s first retirement community in 1990, two thoughts emerged as the driving force: If my parents were to live in a retirement community, what would I want it to be like? And how would I want them to be treated? From these simple concepts, Kisco`s philosophy was shaped. We created our Principles, Values and Beliefs based on integrity, dignity and compassion. This belief system balances the needs of our residents, our employees – whom we regard as associates – and our business partners. Today our organization is nationwide, but we maintain a personal approach. We continuously reevaluate and refine our methods. We treat people with kindness and respect. We work to create environments that are inviting to residents, their families, and friends. We listen. At Kisco Senior Living, we aren`t aiming to be the biggest. We are aiming to be the best.
Health Dimensions is a Carlsbad, CA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
lcelyx was founded in 2010 with venture capital backing based on Gut Sensory Modulation (GSM) technology. Elcelyx`s proprietary, first-in-class Gut Sensory Modulators are delivered directly to the lower gut where they act on molecular targets to elicit physiological and pharmacological effects. The Elcelyx proprietary product candidate, NewMet for Type 2 diabetes is entering Phase 2b development and is a blockbuster opportunity designed to address the unmet needs in the oral anti-diabetic market. Elcelyx is led by an experienced management team and Board of Directors with track records of success in drug development and commercialization. Premier investors along with seasoned scientists and clinicians support the team. In September 2013, Elcelyx announced the formation of NaZura BioHealth Inc, a separate company established to focus on the development on non-NewMet assets.